- Home
- TNGX vs MG Comparison
TNGX vs MG Comparison
Compare TNGX & MG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- MG
- Stock Information
- Founded
- TNGX 2014
- MG 1978
- Country
- TNGX United States
- MG United States
- Employees
- TNGX N/A
- MG N/A
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- MG Military/Government/Technical
- Sector
- TNGX Health Care
- MG Consumer Discretionary
- Exchange
- TNGX Nasdaq
- MG Nasdaq
- Market Cap
- TNGX 317.4M
- MG 303.0M
- IPO Year
- TNGX N/A
- MG 2009
- Fundamental
- Price
- TNGX $1.77
- MG $9.88
- Analyst Decision
- TNGX Strong Buy
- MG Hold
- Analyst Count
- TNGX 7
- MG 1
- Target Price
- TNGX $12.33
- MG $11.00
- AVG Volume (30 Days)
- TNGX 782.3K
- MG 139.0K
- Earning Date
- TNGX 05-07-2025
- MG 03-05-2025
- Dividend Yield
- TNGX N/A
- MG N/A
- EPS Growth
- TNGX N/A
- MG N/A
- EPS
- TNGX N/A
- MG 0.60
- Revenue
- TNGX $42,069,000.00
- MG $729,640,000.00
- Revenue This Year
- TNGX N/A
- MG $5.79
- Revenue Next Year
- TNGX N/A
- MG $3.26
- P/E Ratio
- TNGX N/A
- MG $16.45
- Revenue Growth
- TNGX 15.17
- MG 3.43
- 52 Week Low
- TNGX $1.72
- MG $7.45
- 52 Week High
- TNGX $12.02
- MG $12.44
- Technical
- Relative Strength Index (RSI)
- TNGX 32.71
- MG 50.08
- Support Level
- TNGX $1.80
- MG $9.75
- Resistance Level
- TNGX $2.04
- MG $10.45
- Average True Range (ATR)
- TNGX 0.21
- MG 0.43
- MACD
- TNGX 0.01
- MG -0.00
- Stochastic Oscillator
- TNGX 7.46
- MG 49.44
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About MG Mistras Group Inc
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.